CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Recruiting now

Conditions studied: Generalized Pustular Psoriasis

In brief

Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target

Key facts

Study ID

NCT06100991

Run by

CorEvitas

People needed

200

Starts

2023-09-19

Expected to finish

2099-12-01

Last updated by the study team

2026-02-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• A subject must meet all the following criteria to participate in the registry:
• Has been diagnosed with GPP by a dermatologist or a qualified dermatology practitioner.
• Is at least 18 years of age and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted.
• Is willing to provide consent for participation in the registry.
• Is willing to provide Personal Information

You may not qualify if…

• Any of the following would exclude the subject from participating in the registry:
• Is participating or planning to participate in a blinded clinical trial evaluating a systemic agent for the treatment or prevention of flares related to GPP.
• Is enrolled in another CorEvitas registry for a dermatological condition. Subjects enrolled in another CorEvitas registry must be exited to be eligible for enrollment into the GPP Registry

Where it is running

• CorEvitas, LLC — Waltham, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.